Showing results (401-410 of 465) with videos related to
Sort By:
Pageof 47
ACS Omega|November 29, 2023
Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET AgentsZehua Sun, Ambika P Jaswal, Xiaojie Chu, et al.Energy & Environmental Science|January 10, 2017
Reduced voltage losses yield 10% efficient fullerene free organic solar cells with >1 V open circuit voltagesD Baran, T Kirchartz, S Wheeler, et al.Journal of Virology|February 28, 2006
Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletionMichele Di Mascio, Irini Sereti, Lynn T Matthews, et al.Science Translational Medicine|August 9, 2019
Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse modelKim Anthony-Gonda, Ariola Bardhi, Alex Ray, et al.Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.Journal of Virology|August 17, 2004
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibodyMei-Yun Zhang, Xiaodong Xiao, Igor A Sidorov, et al.Plos Pathogens|November 6, 2009
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infectionKatharine N Bossart, Zhongyu Zhu, Deborah Middleton, et al.Mabs|August 8, 2024
Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancerXiaojie Chu, Seungmin Shin, Du-San Baek, et al.Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexesMaxime Moulard, Sanjay K Phogat, Yuuei Shu, et al.NPJ Vaccines|December 20, 2024
Establishing an immune correlate of protection for Nipah virus in nonhuman primatesV H Leyva-Grado, D Promeneur, K N Agans, et al.Pageof 47